Compositions and methods for the treatment of cystic fibrosis
CA 2324426 A1 · Owner: Perrine, Susan P. · Inventors: Perrine, Susan P.; Stamatoyannopoulos, George; Faller, Douglas V.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention is directed to novel pharmaceutical compositions comprising chemical agents that are useful in the treatment and prevention of cystic fibrosis and the prevention of signs and symptoms of this disease. These pharmaceutical compositions are surprisingly successful in the treatment of disorders related to cystic fibrosis including disorders of blood production. Many of these compositions of the invention are even more effective when administered to a patient in pulses. Pulse therapy is not a form of discontinuous administration of the same amount of a composition over time but comprises administration of the same dose of the composition at a reduced frequency or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 11, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 11, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 11, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.